Hemarina
Morlaix, FR· latest recorded location
HEMARINA is named on 9 US grants and 18 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 9
- Published applications
- 18
- Inventors
- 12
- Granted in 2026 so far
- 0
- Most recent grant
- 25 Jun 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 1 | 2 |
| 2015 | 1 | 2 |
| 2016 | 0 | 2 |
| 2017 | 1 | 0 |
| 2018 | 2 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 2 | 3 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 27 documents
- A61KMedicines and medical preparations19
- A61PTherapeutic uses of medicines15
- A01NPreservation of bodies of humans or animals or plants or parts thereof10
- C12NMicroorganisms or enzymes10
- A61QSpecific use of cosmetics or similar toiletry preparations5
- A61LMethods or apparatus for sterilising materials or objects in general4
- C07KPeptides3
- A23JProtein compositions for foodstuffs2
- A23KFodder2
- C12MApparatus for enzymology or microbiology2
Recent patents
- Annelid haemoglobin lyophilisation process25 Jun 2024US 12,016,956 B2
- Heamoglobin and uses thereof18 Jan 2022US 11,224,218 B2
- Use of a hemoglobin for the preparation of dressings and resulting dressings31 Aug 2021US 11,103,615 B2
- Sand worm lyophilisate and uses thereof27 Apr 2021US 10,988,730 B2
- Bioreactor using oxygen-carrying molecules6 Nov 2018US 10,119,110 B2
- Use of an annelid molecule for treating and/or preventing at least one complement-activation associated disease5 Feb 2026US 2026/0035417 A1
- Annelid hemoglobin for use in the treatment of fuchs' disease20 Nov 2025US 2025/0352616 A1
- Gel based on annelid hemoglobin16 May 2024US 2024/0156918 A1
- Use of haemoglobin from annelids for treating acute respiratory distress syndrome27 Apr 2023US 2023/0127721 A1
- Use of annelid haemoglobin in vitro15 Sep 2022US 2022/0287295 A1
Most cited
By later US patents
- Use of a globin, a globin protomer or an extracellular hemoglobin obtained from the marine worm, Arenicola marina, for the preservation of organs, tissues, cells or cell cultures3US 8,846,306 B22014
- Use of extracellular hemoglobin obtained from the marine worm, Arenicola marina, for the preservation of organs, tissues, cells2US 9,861,095 B22018
- Heamoglobin and uses thereof1US 11,224,218 B22022